|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 4 (February 15), 2000:
pp. 1386-1392
Abundant Tax protein expression in CD4+ T cells infected with
human T-cell lymphotropic virus type I (HTLV-I) is prevented by
cytotoxic T lymphocytes
Emmanuel Hanon,
Sarah Hall,
Graham P. Taylor,
Mineki Saito,
Ricardo Davis,
Yuetsu Tanaka,
Koichiro Usuku,
Mitsuhiro Osame,
Jonathan N. Weber, and
Charles R. M. Bangham
From the Department of Immunology and Genito-Urinary Medicine and
Communicable Diseases, Imperial College School of Medicine, St Mary's
Campus, London, United Kingdom; Department of Infectious Disease and
Immunology, Okinawa-Asia Research Center of Medical Science, Faculty of
Medicine, University of The Ryukyus, Nishihara, Okinawa, Japan; and
Department of Medical Informatics and Third Department of Internal
Medicine, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.
The role of the cellular immune response in human T-cell leukemia
virus type I (HTLV-I) infection is not fully understood. A persistently
activated cytotoxic T lymphocyte (CTL) response to HTLV-I is found in
the majority of infected individuals. However, it remains unclear
whether this CTL response is protective or causes tissue damage. In
addition, several observations paradoxically suggest that HTLV-I is
transcriptionally silent in most infected cells and, therefore, not
detectable by virus-specific CTLs. With the use of a new flow
cytometric procedure, we show here that a high proportion of naturally
infected CD4+ peripheral blood mononuclear cells (PBMC) (between 10%
and 80%) are capable of expressing Tax, the immunodominant target
antigen recognized by virus-specific CTLs. Furthermore, we provide
direct evidence that autologous CD8+ T cells rapidly kill CD4+
cells naturally infected with HTLV-I and expressing Tax in vitro by a
perforin-dependent mechanism. Consistent with these observations, we
observed a significant negative correlation between the frequency of
Tax11-19-specific CD8+ T cells and the percentage of
CD4+ T cells in peripheral blood of patients infected with HTLV-I.
Those results are in accordance with the view that virus-specific CTLs
participate in a highly efficient immune surveillance mechanism that
persistently destroys Tax-expressing HTLV-I-infected CD4+ T cells in vivo.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Kinpara, A. Hasegawa, A. Utsunomiya, H. Nishitsuji, H. Furukawa, T. Masuda, and M. Kannagi
Stromal Cell-Mediated Suppression of Human T-Cell Leukemia Virus Type 1 Expression In Vitro and In Vivo by Type I Interferon
J. Virol.,
May 15, 2009;
83(10):
5101 - 5108.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Kattan, A. MacNamara, A. G. Rowan, H. Nose, A. J. Mosley, Y. Tanaka, G. P. Taylor, B. Asquith, and C. R. M. Bangham
The Avidity and Lytic Efficiency of the CTL Response to HTLV-1
J. Immunol.,
May 1, 2009;
182(9):
5723 - 5729.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. H. Sabouri, K. Usuku, D. Hayashi, S. Izumo, Y. Ohara, M. Osame, and M. Saito
Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease
Blood,
September 15, 2008;
112(6):
2411 - 2420.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Enose-Akahata, U. Oh, C. Grant, and S. Jacobson
Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease
Blood,
September 15, 2008;
112(6):
2400 - 2410.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Toulza, A. Heaps, Y. Tanaka, G. P. Taylor, and C. R. M. Bangham
High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response
Blood,
May 15, 2008;
111(10):
5047 - 5053.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Pichler, T. Kattan, J. Gentzsch, A. K. Kress, G. P. Taylor, C. R. M. Bangham, and R. Grassmann
Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral Tax oncoprotein
Blood,
May 1, 2008;
111(9):
4741 - 4751.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Jain, J. Ahuja, Z. K. Khan, S. Shimizu, O. Meucci, S. R. Jennings, and B. Wigdahl
Modulation of dendritic cell maturation and function by the Tax protein of human T cell leukemia virus type 1
J. Leukoc. Biol.,
July 1, 2007;
82(1):
44 - 56.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Asquith, Y. Zhang, A. J. Mosley, C. M. de Lara, D. L. Wallace, A. Worth, L. Kaftantzi, K. Meekings, G. E. Griffin, Y. Tanaka, et al.
In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection
PNAS,
May 8, 2007;
104(19):
8035 - 8040.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Mosley, K. N. Meekings, C. McCarthy, D. Shepherd, V. Cerundolo, R. Mazitschek, Y. Tanaka, G. P. Taylor, and C. R. Bangham
Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection
Blood,
December 1, 2006;
108(12):
3801 - 3807.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Miyazato, J.-i. Yasunaga, Y. Taniguchi, Y. Koyanagi, H. Mitsuya, and M. Matsuoka
De Novo Human T-Cell Leukemia Virus Type 1 Infection of Human Lymphocytes in NOD-SCID, Common {gamma}-Chain Knockout Mice
J. Virol.,
November 1, 2006;
80(21):
10683 - 10691.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Kozako, N. Arima, S. Toji, I. Masamoto, M. Akimoto, H. Hamada, X.-F. Che, H. Fujiwara, K. Matsushita, M. Tokunaga, et al.
Reduced Frequency, Diversity, and Function of Human T Cell Leukemia Virus Type 1-Specific CD8+ T Cell in Adult T Cell Leukemia Patients
J. Immunol.,
October 15, 2006;
177(8):
5718 - 5726.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kobayashi, T. Ngato, K. Sato, N. Aoki, S. Kimura, Y. Tanaka, H. Aizawa, M. Tateno, and E. Celis
In vitro Peptide Immunization of Target Tax Protein Human T-Cell Leukemia Virus Type 1-Specific CD4+ Helper T Lymphocytes.
Clin. Cancer Res.,
June 15, 2006;
12(12):
3814 - 3822.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Krueger, S. C. Fas, M. Giaisi, M. Bleumink, A. Merling, C. Stumpf, S. Baumann, D. Holtkotte, V. Bosch, P. H. Krammer, et al.
HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP)
Blood,
May 15, 2006;
107(10):
3933 - 3939.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nejmeddine, A. L. Barnard, Y. Tanaka, G. P. Taylor, and C. R. M. Bangham
Human T-lymphotropic Virus, Type 1, Tax Protein Triggers Microtubule Reorientation in the Virological Synapse
J. Biol. Chem.,
August 19, 2005;
280(33):
29653 - 29660.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Barnard, T. Igakura, Y. Tanaka, G. P. Taylor, and C. R.M. Bangham
Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes
Blood,
August 1, 2005;
106(3):
988 - 995.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Asquith, A. J. Mosley, A. Barfield, S. E. F. Marshall, A. Heaps, P. Goon, E. Hanon, Y. Tanaka, G. P. Taylor, and C. R. M. Bangham
A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load
J. Gen. Virol.,
May 1, 2005;
86(5):
1515 - 1523.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Lemey, S. Van Dooren, and A.-M. Vandamme
Evolutionary Dynamics of Human Retroviruses Investigated Through Full-Genome Scanning
Mol. Biol. Evol.,
April 1, 2005;
22(4):
942 - 951.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Chiari, I. Lamsoul, J. Lodewick, C. Chopin, F. Bex, and C. Pique
Stable Ubiquitination of Human T-Cell Leukemia Virus Type 1 Tax Is Required for Proteasome Binding
J. Virol.,
November 1, 2004;
78(21):
11823 - 11832.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Vine, A. G. Heaps, L. Kaftantzi, A. Mosley, B. Asquith, A. Witkover, G. Thompson, M. Saito, P. K. C. Goon, L. Carr, et al.
The Role of CTLs in Persistent Viral Infection: Cytolytic Gene Expression in CD8+ Lymphocytes Distinguishes between Individuals with a High or Low Proviral Load of Human T Cell Lymphotropic Virus Type 1
J. Immunol.,
October 15, 2004;
173(8):
5121 - 5129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Dodon, Z. Li, S. Hamaia, and L. Gazzolo
Tax protein of human T-cell leukaemia virus type 1 induces interleukin 17 gene expression in T cells
J. Gen. Virol.,
July 1, 2004;
85(7):
1921 - 1932.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Sanchez Alcaraz, P. Kerkhofs, M. Reichert, R. Kettmann, and L. Willems
Involvement of Glutathione as a Mechanism of Indirect Protection against Spontaneous Ex Vivo Apoptosis Associated with Bovine Leukemia Virus
J. Virol.,
June 15, 2004;
78(12):
6180 - 6189.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Yamano, C. J. Cohen, N. Takenouchi, K. Yao, U. Tomaru, H.-C. Li, Y. Reiter, and S. Jacobson
Increased Expression of Human T Lymphocyte Virus Type I (HTLV-I) Tax11-19 Peptide-Human Histocompatibility Leukocyte Antigen A*201 Complexes on CD4+ CD25+ T Cells Detected by Peptide-specific, Major Histocompatibility Complex-restricted Antibodies in Patients with HTLV-I-associated Neurologic Disease
J. Exp. Med.,
May 17, 2004;
199(10):
1367 - 1377.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. K. C. Goon, T. Igakura, E. Hanon, A. J. Mosley, A. Barfield, A. L. Barnard, L. Kaftantzi, Y. Tanaka, G. P. Taylor, J. N. Weber, et al.
Human T Cell Lymphotropic Virus Type I (HTLV-I)-Specific CD4+ T Cells: Immunodominance Hierarchy and Preferential Infection with HTLV-I
J. Immunol.,
February 1, 2004;
172(3):
1735 - 1743.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. R. M. Bangham
The immune control and cell-to-cell spread of human T-lymphotropic virus type 1
J. Gen. Virol.,
December 1, 2003;
84(12):
3177 - 3189.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. K. C. Goon, T. Igakura, E. Hanon, A. J. Mosley, B. Asquith, K. G. Gould, G. P. Taylor, J. N. Weber, and C. R. M. Bangham
High Circulating Frequencies of Tumor Necrosis Factor Alpha- and Interleukin-2-Secreting Human T-Lymphotropic Virus Type 1 (HTLV-1)-Specific CD4+ T Cells in Patients with HTLV-1-Associated Neurological Disease
J. Virol.,
September 1, 2003;
77(17):
9716 - 9722.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Saito, V. M. Braud, P. Goon, E. Hanon, G. P. Taylor, A. Saito, N. Eiraku, Y. Tanaka, K. Usuku, J. N. Weber, et al.
Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers
Blood,
July 15, 2003;
102(2):
577 - 584.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Nasr, A. Rosenwald, M. E. El-Sabban, B. Arnulf, P. Zalloua, Y. Lepelletier, F. Bex, O. Hermine, L. Staudt, H. de The, et al.
Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells
Blood,
June 1, 2003;
101(11):
4576 - 4582.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Kubota, Y. Furukawa, S. Izumo, K. Usuku, and M. Osame
Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP)
Blood,
April 15, 2003;
101(8):
3074 - 3081.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Debacq, B. Asquith, P. Kerkhofs, D. Portetelle, A. Burny, R. Kettmann, and L. Willems
Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep
PNAS,
July 23, 2002;
99(15):
10048 - 10053.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Wang, H. Miyake, M. Okamoto, M. Saito, J.-I. Fujisawa, Y. Tanaka, S. Izumo, and M. Baba
Inhibition of the Tax-Dependent Human T-Lymphotropic Virus Type I Replication in Persistently Infected Cells by the Fluoroquinolone Derivative K-37
Mol. Pharmacol.,
June 1, 2002;
61(6):
1359 - 1365.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Haller, Y. Wu, E. Derow, I. Schmitt, K.-T. Jeang, and R. Grassmann
Physical Interaction of Human T-Cell Leukemia Virus Type 1 Tax with Cyclin-Dependent Kinase 4 Stimulates the Phosphorylation of Retinoblastoma Protein
Mol. Cell. Biol.,
May 15, 2002;
22(10):
3327 - 3338.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. K. C. Goon, E. Hanon, T. Igakura, Y. Tanaka, J. N. Weber, G. P. Taylor, and C. R. M. Bangham
High frequencies of Th1-type CD4+ T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis
Blood,
May 1, 2002;
99(9):
3335 - 3341.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. El-Sabban, R. A. Merhi, H. A. Haidar, B. Arnulf, H. Khoury, J. Basbous, J. Nijmeh, H. de The, O. Hermine, and A. Bazarbachi
Human T-cell lymphotropic virus type 1-transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells
Blood,
May 1, 2002;
99(9):
3383 - 3389.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Lomas, E. Hanon, Y. Tanaka, C. R. M. Bangham, and K. G. Gould
Presentation of a new H-2Dk-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin
J. Gen. Virol.,
March 1, 2002;
83(3):
641 - 650.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Furuta, K. Sugiura, S. Kawakita, T. Inada, S. Ikehara, T. Matsuda, and J.-i. Fujisawa
Mouse Model for the Equilibration Interaction between the Host Immune System and Human T-Cell Leukemia Virus Type 1 Gene Expression
J. Virol.,
February 22, 2002;
76(6):
2703 - 2713.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Yamano, M. Nagai, M. Brennan, C. A. Mora, S. S Soldan, U. Tomaru, N. Takenouchi, S. Izumo, M. Osame, and S. Jacobson
Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP)
Blood,
January 1, 2002;
99(1):
88 - 94.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nagai, M. B. Brennan, J. A. Sakai, C. A. Mora, and S. Jacobson
CD8+ T cells are an in vivo reservoir for human T-cell lymphotropic virus type I
Blood,
September 15, 2001;
98(6):
1858 - 1861.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Sakai, M. Nagai, M. B. Brennan, C. A. Mora, and S. Jacobson
In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: predominant expansion of CD8+ T cells
Blood,
September 1, 2001;
98(5):
1506 - 1511.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Hanon, P. Goon, G. P. Taylor, H. Hasegawa, Y. Tanaka, J. N. Weber, and C. R. M. Bangham
High production of interferon {gamma} but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells
Blood,
August 1, 2001;
98(3):
721 - 726.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Overbaugh and C. R. M. Bangham
Selection Forces and Constraints on Retroviral Sequence Variation
Science,
May 11, 2001;
292(5519):
1106 - 1109.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
F. Mortreux, I. Leclercq, A.-S. Gabet, A. Leroy, E. Westhof, A. Gessain, S. Wain-Hobson, and E. Wattel
Somatic Mutation in Human T-Cell Leukemia Virus Type 1 Provirus and Flanking Cellular Sequences During Clonal Expansion In Vivo
J Natl Cancer Inst,
March 7, 2001;
93(5):
367 - 377.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Saito, G. P. Taylor, A. Saito, Y. Furukawa, K. Usuku, J. N. Weber, M. Osame, and C. R. M. Bangham
In Vivo Selection of T-Cell Receptor Junctional Region Sequences by HLA-A2 Human T-Cell Lymphotropic Virus Type 1 Tax11-19 Peptide Complexes
J. Virol.,
January 15, 2001;
75(2):
1065 - 1071.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
F. Mortreux, M. Kazanji, A.-S. Gabet, B. de Thoisy, and E. Wattel
Two-Step Nature of Human T-Cell Leukemia Virus Type 1 Replication in Experimentally Infected Squirrel Monkeys (Saimiri sciureus)
J. Virol.,
January 15, 2001;
75(2):
1083 - 1089.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K. J. M. Jeffery, A. A. Siddiqui, M. Bunce, A. L. Lloyd, A. M. Vine, A. D. Witkover, S. Izumo, K. Usuku, K. I. Welsh, M. Osame, et al.
The Influence of HLA Class I Alleles and Heterozygosity on the Outcome of Human T Cell Lymphotropic Virus Type I Infection
J. Immunol.,
December 15, 2000;
165(12):
7278 - 7284.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
